Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018;95(5):334-342.
doi: 10.1159/000485935. Epub 2018 Jan 25.

Increased Small Intestinal Permeability during Severe Acute Exacerbations of COPD

Affiliations

Increased Small Intestinal Permeability during Severe Acute Exacerbations of COPD

Roy T M Sprooten et al. Respiration. 2018.

Abstract

Background: Disturbances of intestinal integrity, manifested by increased gastro-intestinal (GI) permeability, have been found in chronic obstructive pulmonary disease (COPD) patients during physical activity, often associated with intermittent hypoxic periods. Evidence about extrapulmonary organ disturbances, especially of the GI tract, during hospitalised acute exacerbation of COPD (AE-COPD) with hypoxaemic respiratory failure (RF) is lacking.

Objective: The aim was to assess changes in GI permeability in patients with AE-COPD and during recovery 4 weeks later.

Methods: All patients admitted to our hospital with AE-COPD accompanied by hypoxaemia at admission (PaO2 <8.7 kPa or O2 saturation <93%) were screened between October 2013 and February 2014. Patients with a history of GI or renal disease, chronic heart failure, or use of non-steroidal anti-inflammatory drugs in the 48 h before the test were excluded. GI permeability was assessed by evaluating urinary excretion ratios of the orally ingested sugars lactulose/L-rhamnose (L/R ratio), sucrose/L-rhamnose (Su/R ratio) and sucralose/erythritol (S/E ratio).

Results: Seventeen patients with severe to very severe COPD completed the study. L/R ratio (×103) at admission of AE-COPD was significantly higher than in the recovery condition (40.9 [29.4-49.6] vs. 27.3 [19.5-47.7], p = 0.039), indicating increased small intestinal permeability. There were no significant differences in the individual sugar levels in urine nor in the 0- to 5-h urinary S/E and Su/R ratios between the 2 visits.

Conclusion: This is the first study showing increased GI permeability during hospitalised AE-COPD accompanied by hypoxaemic RF. Therefore, GI integrity in COPD patients is an attractive target for future research and for the development of interventions to alleviate the consequences of AE-COPD.

Keywords: Barrier function; Hospital admission; Hypoxaemia; Lactulose/L-rhamnose ratio; Small intestine.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Flowchart of the subject selection. AE-COPD, acute exacerbation of chronic obstructive pulmonary disease.
Fig. 2
Fig. 2
Gastrointestinal permeability during AE-COPD (visit 1) compared to stable condition (visit 2) according to 0- to 5-h urinary L/R ratio (×103) (a), S/E ratio (×103) (b), and Su/R ratio (×103) (c). * p value < 0.05. AE-COPD, acute exacerbation of chronic obstructive pulmonary disease; L/R ratio, lactulose/L-rhamnose ratio; S/E ratio, sucralose/erythritol ratio; Su/R ratio, sucrose/L-rhamnose ratio.

References

    1. Wedzicha JA, Seemungal TA. COPD exacerbations: defining their cause and prevention. Lancet. 2007;370:786–796. - PMC - PubMed
    1. van Eeden SF, Sin DD. Chronic obstructive pulmonary disease: a chronic systemic inflammatory disease. Respiration. 2008;75:224–238. - PubMed
    1. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS, Committee GS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001;163:1256–1276. - PubMed
    1. Celli BR. MacNee W; ATS/ERS Task Force: Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23:932–946. - PubMed
    1. John BA, Wood SG, Hawkins DR. The pharmacokinetics and metabolism of sucralose in the mouse. Food Chem Toxicol. 2000;38((suppl 2)):S107–S110. - PubMed